Beyond the Lab – Episode 4

Beyond the Lab – Episode 4

Beyond the Lab Episode 4 🚨 The 4th episode of our Beyond the Lab interview series is now live! 🎉   In this episode, we talk with Cali Roiboit, a Provisional Psychologist and PhD candidate in Clinical Neuropsychology at Monash University. Cali’s research focuses...
Life Insurance Ban on Genetic Discrimination

Life Insurance Ban on Genetic Discrimination

Australia’s Landmark Move with Life Insurance Life Insurers Prohibited from Using Genetic Tests to Deny Coverage or Increase Premiums   Following the recommendations of a report led by Monash University’s Dr. Jane Tiller and Professor Paul Lacaze, the Australian...
SKY-0515 Clinical Trial

SKY-0515 Clinical Trial

SKY-0515 Clinical Trial A Small Molecule Promises Big! In February 2024, Skyhawk Therapeutics, a biotechnology company at the forefront of developing innovative treatments, made a significant progress in the fight against Huntington’s disease. With no approved...
The AMT-130 Study

The AMT-130 Study

The AMT-130 Study An Exciting development in the Huntington’s research space. uniQure has released encouraging interim results from the AMT-130 therapy trials for Huntington’s Disease (HD). Since the trials began, AMT-130 has faced some challenges. Initial...
The AMT-130 Study

SELECT-HD Trial Update

SELECT-HD Trial Update A promising step forward for the Huntington’s Disease Community Wave Life Sciences Ltd. recently announced positive results from their SELECT-HD trial (NCT05032196), a global multicenter, double-blind, placebo-controlled, Phase 1b/2a...